Page last updated: 2024-08-24

isothiocyanic acid and Retinal Neovascularization

isothiocyanic acid has been researched along with Retinal Neovascularization in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chikaraishi, Y; Hara, H; Shimazawa, M; Yokota, K; Yoshino, K1

Other Studies

1 other study(ies) available for isothiocyanic acid and Retinal Neovascularization

ArticleYear
CB-12181, a new azasugar-based matrix metalloproteinase/tumor necrosis factor-alpha converting enzyme inhibitor, inhibits vascular endothelial growth factor-induced angiogenesis in vitro and retinal neovascularization in vivo.
    Current neurovascular research, 2009, Volume: 6, Issue:3

    Topics: ADAM Proteins; ADAM17 Protein; Angiogenesis Inhibitors; Animals; Animals, Newborn; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Endothelial Cells; Enzyme Inhibitors; Humans; Hydroxamic Acids; Ischemia; Isothiocyanates; Mice; Mice, Inbred C57BL; Retinal Neovascularization; Sulfones; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

2009